Tag Archive for: Agomab

Another strong financing round for Belgian Agomab NV. Sanofi is joining the band wagon of targeting the TGFbeta receptor.

Belgian fibrosis specialist Agomab Therapeutics NV has raised US$100m to advance development of its pipeline.